pharmaphorum renews strategic media partnership with Frontie...
pharmaphorum is proud to announce its renewed strategic media partnership with Frontiers Health 2026.
NICE backs Sobi's Tryngolza for rare disease FCS
Patients in England and Wales with familial chylomicronaemia syndrome will soon have a new treatment option, as NICE backs Sobi's Tryngolza.
Bayer names Christoph Koenen as its new CMO
Bayer has looked internally for its chief medical officer, appointing Christoph Koenen to the post alongside his current clinical development role.
Sanofi forges new $8bn pact with Regeneron
Sanofi's long-running R&D alliance with Regeneron has gone up a gear with a new deal – including a $1bn upfront payment – that spans four new drugs.
GLOBE model finalised, with narrowed scope and fewer savings
CMS has finalised a new drug pricing policy for Medicare that has drawn sharp criticism from the pharma industry.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
3rd Annual Personalized Cancer Vaccine Summit 2026 | Decembe...
The 3rd Annual Personalized Cancer Vaccine Summit brings together leaders from across companies to share data-driven insights
CPHI Milan 2026 showcases new Sustainability Summit
The first-time event will bring delegates together to discuss sustainability challenges
Pharmaceutical thought leaders gather at CPHI Milan 2026
Industry leaders will address topics such as manufacturing transformation and future therapies
5th Sustainability in Life Sciences Summit
Join the global sustainability community this November in Boston
CPHI Milan Leadership Summit returns for 2026
Senior pharma leaders will tackle resilience, policy, and industry transformation at CPHI Milan